D-1205-2018 Class III Terminated

Recalled by Jubilant Cadista Pharmaceuticals, Inc. — Salisbury, MD

FDA drug recall D-1205-2018 was initiated by Jubilant Cadista Pharmaceuticals, Inc. on Aug 27, 2018 and is designated Class III. Reason for recall: Failed Stability Specifications: An out-of-specification result was obtained during 18-month stability testing for assay. The recall status is terminated (terminated Oct 8, 2019). Affected quantity: 89,722 blister pack.

Recall details

Product Type
Drugs
Report Date
Sep 26, 2018
Initiation Date
Aug 27, 2018
Termination Date
Oct 8, 2019
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
89,722 blister pack

Product description

MethylPREDNISolone Tablets, USP, 4 mg, 21-count blister pack. Rx Only. Jubilant Cadista Pharmaceuticals Inc. Salisbury, MD NDC 59746-001-03

Reason for recall

Failed Stability Specifications: An out-of-specification result was obtained during 18-month stability testing for assay.

Distribution pattern

Product was distributed throughout the United States.

Code information

Lot # 17P0078, exp. date 12/2018

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1205-2018
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1205-2018. Report a data issue: hello@regdatalab.com.